How have the 2016 Canadian Cardiovascular Society Guidelines for LDL-C reduction positioned their recommendations for LDL-C target goals, and how do you anticipate these might change in the future based on the ODYSSEY Outcomes and FOURIER Trials?

How have the 2016 Canadian Cardiovascular Society Guidelines for LDL-C reduction positioned their recommendations for LDL-C target goals, and how do you anticipate these might change in the future based on the ODYSSEY Outcomes and FOURIER Trials?

How have the 2016 Canadian Cardiovascular Society Guidelines for LDL-C reduction positioned their recommendations for LDL-C target goals, and how do you anticipate these might change in the future based on the ODYSSEY Outcomes and FOURIER Trials? 


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Shaun Goodman, MD, MSc, FRCPC, FACC, FESC, FAHA

Shaun Goodman, MD, MSc, FRCPC, FACC, FESC, FAHA

Associate Head, Division of Cardiology St. Michael’s Hospital